Macadildig, Vicente S.

HRN: 12-59-45  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2022
CEFTAZIDIME 1GM (VIAL)
08/23/2022
08/29/2022
IV
1g
Q8H
Community Acquired Pneumonia - Moderate Risk
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: